Breakthrough Prizes 2026: $18M Rewards US-Led Gene Therapies and Muon Precision Physics

Breakthrough Prize Foundation awarded six $3 million prizes on April 18, 2026, totaling $18 million for gene therapies targeting sickle cell disease and beta-thalassemia. US-led Muon g-2 teams at Fermilab and Brookhaven achieved 127 parts-per-billion precision on the muon’s anomalous magnetic moment, 30,000 times better than the 1965 benchmark. These advances drive $100 billion biotech and physics markets forward.